Literature DB >> 7158317

Clinical evaluation of the Lotmar Visometer for macula testing in cataract patients.

P Bernth-Petersen, K Naeser.   

Abstract

This study is an independent clinical evaluation of the 'Lotmar Visometer', an achromatic interferometer that uses moiré fringes with variable pitch making quantitative assessment of macular function possible. Light source is a normal low-voltage lamp. We evaluated this instrument's ability to predict post-operative visual acuity in 90 consecutive cataract patients. 27% could not see the fringes. Among the rest of the patients the correlation between the instrument's prediction and post-operative visual acuity was generally poor. When used semiquantitatively or qualitatively, the visometer, however, can provide useful information of the macular function in some patients.

Entities:  

Mesh:

Year:  1982        PMID: 7158317     DOI: 10.1111/j.1755-3768.1982.tb00597.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  5 in total

1.  Interferometer assessment of potential visual acuity before YAG capsulotomy: relative performance of three instruments.

Authors:  N Strong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

Review 2.  Assessing retinal/neural function in the presence of ocular media opacities.

Authors:  P V McGraw; B T Barrett
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-04       Impact factor: 3.117

3.  Prediction of visual outcome after retinal detachment surgery using the Lotmar visometer.

Authors:  B Yazici; O Gelişken; R Avci; A Yücel
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

4.  Comparison of 2 interferometers for predicting visual acuity in patients with cataract.

Authors:  B L Halliday; J E Ross
Journal:  Br J Ophthalmol       Date:  1983-05       Impact factor: 4.638

5.  Preoperative prediction of postoperative visual acuity in patients with cataracts: a quantitative review.

Authors:  J V Odom; G M Chao; G W Weinstein
Journal:  Doc Ophthalmol       Date:  1988-09       Impact factor: 2.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.